Immunotech Laboratories, Inc. is a drug development company. The Company offers a drug platform, Irreversible Pepsin Fraction (IPF), which is a technology that can be used to facilitate a range of applications. Its flagship compound Immune Therapeutic Vaccine-1 (ITV-1) is a suspension of IPF, which is used in the treatment of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and Hepatitis C viruses and to modulate the immune system. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. The IPF modulates helper T1 cells expression of elaborate cytokines interferon (INF)-gamma, interleukin-2 (IL-2), which selectively promotes cell-mediated immune response and subsequently stimulates cytotoxic lymphocytes. The Company's other compounds in its pipeline include ITV-2 prenatal, ITV-3 Pediatric and ITV-4 HIV Vaccine.